Avai Bio (AVAI) Enterprise Value (2020 - 2026)

Avai Bio has disclosed Enterprise Value across 7 years of filings, most recently posting $19.9 million for Q2 2026.

• In Q2 2026, Enterprise Value fell 75.44% year-over-year to $19.9 million; the TTM figure through Jun 2026 stood at $19.9 million (down 75.44% YoY), while the FY2026 annual figure was $49.0 million, down 25.59% from the prior year.
• Enterprise Value came in at $19.9 million for Q2 2026 at Avai Bio, down from $49.0 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $100.6 million in Q2 2024 to a low of $19.9 million in Q2 2026.
• Average Enterprise Value over 5 years is $57.8 million, with a median of $56.8 million recorded in 2023.
• Year-over-year, Enterprise Value surged 205.54% in 2023 and tumbled 75.44% in 2026.
• Over 5 years, Enterprise Value stood at $40.8 million in 2022, then soared by 39.34% to $56.8 million in 2023, then rose by 25.51% to $71.3 million in 2024, then decreased by 26.51% to $52.4 million in 2025, then plunged by 61.98% to $19.9 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $19.9 million in Q2 2026, $49.0 million in Q1 2026, and $52.4 million in Q4 2025.